Educational Intervention Does Not Better Infant Sleep
A new study shows infants whose mothers received aid in managing their sleep duration and self-regulation did not significantly improve in such rates.
Related Articles
Subcutaneous Amycretin Yields Promising Weight Loss in Phase 1b/2a Trial
Subcutaneous amycretin achieved up to a 22.0% weight loss over 36 weeks, with a consistent safety profile to other incretin-based therapies.
AGA Releases Clinical Practice Update on HBV Reactivation Prevention, Treatment
The updated clinical practice guideline addresses new research and clinical developments since the first iteration of the guideline was released in 2014.
Repurposing Medications for the Treatment of Patients with COPD
Joselyn Rojas-Quintero, MD, speaks about her team’s current research into COPD treatment on this issue of The Respiratory Report.
Poor Allergic Rhinitis Symptoms in Air Conditioning May Predict Greater Severity
A new study showed that experiencing worsened allergic rhinitis symptoms in air-conditioned environments may predict disease severity.
Skin of Color Savvy: News Update—SOCS Awards, My Best Winter Skin, & TORPEDO Program
The January 15, 2025 SOCS News Update highlights research ongoing/upcoming initiatives and awards, the My Best Winter Skin Campaign, and the TORPEDO program.
FDA Recalls First Aid Beauty Face Moisturizers Sold in US
This class 2 recall by FDA officials of almost 3000 First Aid Beauty brand face moisturizers resulted from deviation from Current Good Manufacturing Practice regulations.
People With Fibromyalgia May Have Impaired Mitochondrial Function
The lower BHI observed was likely associated with effects on the musculoskeletal system and not the central nervous system.
FDA Grants Tentative Approval to Generic Version of Rifaximin for IBS-D
The approval of Amneal Pharmaceuticals’ generic version of rifaximin 550 mg oral tablets is tentative due to the product’s involvement in litigation.
Repurposing Medications for the Treatment of Patients with COPD
Joselyn Rojas-Quintero, MD, speaks about her team’s current research into COPD treatment on this issue of The Respiratory Report.
Study Identifies Comorbidities of Intermittent Explosive Disorder
A new study identified psychiatric, neurological, and somatic comorbidities of intermittent explosive disorder.